These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23812388)

  • 1. Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism.
    Moniwa N; Varagic J; Simington SW; Ahmad S; Nagata S; Voncannon JL; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H644-50. PubMed ID: 23812388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
    Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chymase in blood pressure control, plasma and tissue angiotensin II, renal Haemodynamics, and excretion in
    Roszkowska-Chojecka MM; Baranowska I; Gawrys O; Sadowski J; Walkowska A; Kalisz M; Litwiniuk A; Kompanowska-Jezierska E
    Clin Exp Hypertens; 2021 Jul; 43(5):392-401. PubMed ID: 33687310
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin(1-7) in the spontaneously hypertensive rat.
    Kohara K; Brosnihan KB; Ferrario CM
    Peptides; 1993; 14(5):883-91. PubMed ID: 8284265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Converting enzyme determines plasma clearance of angiotensin-(1-7).
    Yamada K; Iyer SN; Chappell MC; Ganten D; Ferrario CM
    Hypertension; 1998 Sep; 32(3):496-502. PubMed ID: 9740616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney.
    Westwood BM; Chappell MC
    Peptides; 2012 Jun; 35(2):190-5. PubMed ID: 22490446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue.
    Ahmad S; Simmons T; Varagic J; Moniwa N; Chappell MC; Ferrario CM
    PLoS One; 2011; 6(12):e28501. PubMed ID: 22180785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of angiotensin peptides in the urine of hypertensive animals.
    Yamada K; Iyer SN; Chappell MC; Brosnihan KB; Fukuhara M; Ferrario CM
    Regul Pept; 1999 Mar; 80(1-2):57-66. PubMed ID: 10235635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.
    Sampson AK; Andrews KL; Graham D; McBride MW; Head GA; Thomas MC; Chin-Dusting JP; Dominiczak AF; Jennings GL
    Hypertension; 2014 Dec; 64(6):1376-83. PubMed ID: 25201895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of delapril on the vascular angiotensin II release in isolated hind legs of the spontaneously hypertensive rat: evidence for potential relevance of vascular angiotensin II to the maintenance of hypertension.
    Mizuno K; Tani M; Niimura S; Fukuchi S
    Clin Exp Pharmacol Physiol; 1991 Sep; 18(9):619-25. PubMed ID: 1959233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.
    Widdop RE; Sampey DB; Jarrott B
    Hypertension; 1999 Oct; 34(4 Pt 2):964-8. PubMed ID: 10523392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N; Satoh C; Hu WY; Soma M; Kubo A; Kishioka H; Watanabe Y; Izumi Y; Kanmatsuse K
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1210-7. PubMed ID: 10323771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition.
    Gonzalez-Villalobos RA; Satou R; Ohashi N; Semprun-Prieto LC; Katsurada A; Kim C; Upchurch GM; Prieto MC; Kobori H; Navar LG
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F150-7. PubMed ID: 19846570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats.
    Lima CV; Paula RD; Resende FL; Khosla MC; Santos RA
    Hypertension; 1997 Sep; 30(3 Pt 2):542-8. PubMed ID: 9322979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
    Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.